All news
5 min read

EU Bans 16 New Cosmetic Ingredients Under Omnibus Act IX and Omnibus Act 3

Brands selling into the EU are looking at another formulation review. On 8 July 2026 the European Commission notified the WTO of a draft update to Regulation (EC) No 1223/2009, informally known as Omnibus Act IX on CMRs and Omnibus Act 3 on Ingredients. Its starting point is Delegated Regulation (EU) 2025/1222, the 23rd Adaptation to Technological Progress, which reclassified a batch of substances as carcinogenic, mutagenic or toxic for reproduction; the draft also folds in SCCS safety opinions issued through 2025 and 2026.

Three annexes are affected: II (the banned-substances list), III (restricted substances) and V (preservatives).
Below is the substance-by-substance breakdown, with the compliance deadline for each.

Annex II: 16 substances added to the banned list

The draft adds 16 substances to Annex II, the EU’s list of ingredients prohibited in cosmetic products:

#SubstanceCASPlacing on the market*Making available*
12-ethylhexanoic acid, monoester with propane-1,2-diol85114-00-71 Feb 20271 Feb 2027
2a,a’-propylenedinitrilodi-o-cresol94-91-71 Feb 20271 Feb 2027
3Ozone10028-15-61 Feb 20271 Feb 2027
4Dinitrogen oxide10024-97-21 Feb 20271 Feb 2027
59-octadecenoic acid (Z)-, sulfonated, potassium salts and related reaction products68609-93-8, 67968-63-21 Feb 20271 Feb 2027
62,3-epoxypropyl isopropyl ether4016-14-21 Feb 20271 Feb 2027
7Tetrahydrofurfuryl methacrylate2455-24-51 Feb 20271 Feb 2027
8Trimethyl phosphate512-56-11 Feb 20271 Feb 2027
9Fluoroethylene75-02-51 Feb 20271 Feb 2027
102-bromo-3,3,3-trifluoroprop-1-ene1514-82-51 Feb 20271 Feb 2027
112-phenylpropene / a-methylstyrene98-83-91 Feb 20271 Feb 2027
12Benzophenone-1131-56-612 months after entry into force24 months after entry into force
13Benzophenone-2131-55-512 months after entry into force24 months after entry into force
14Basic Brown 1626381-41-912 months after entry into force24 months after entry into force
15Basic Blue 9968123-13-712 months after entry into force24 months after entry into force
16Prostaglandins and their analogues–12 months after entry into force24 months after entry into force

*These dates are not yet official. The amendment has only been notified to the WTO as a draft and has not been formally adopted or published, so the dates could still shift. Based on an expected adoption in late 2026, the 12/24-month transitions work out to an estimated late 2027/early 2028 (placing on the market) and late 2028/early 2029 (making available).

Benzophenone-1 and Benzophenone-2 are the ones most likely to affect formulators directly, since both have seen use as UV filters and photostabilisers in sunscreens and other leave-on products. Brands still relying on either should be lining up replacement filters now.

Annex III: Hydroxyapatite (nano), CBD, and BHA

The restriction on Hydroxyapatite (nano) under entry 372 is replaced outright. The maximum concentration rises to 29.5% in toothpaste and 10% in mouthwash, with the ban in every other product category staying in place. Nano forms also pick up tighter particle specifications: at least 87% of rod-shaped particles must have an aspect ratio of 3 or less (the remainder capped at 9), particles must be uncoated and unmodified, and maximum particle length is set at 122 ± 43 nm. Existing CPSRs referencing the old entry will need a review.

Two new entries are added:

IngredientAllowed inMax concentrationConditionPlacing on the market*Making available*
Cannabidiol (CBD), CAS 13956-29-1Leave-on, rinse-off, oral care0.19%THC impurity capped at 0.00025% (2.5 ppm)12 months after entry into force24 months after entry into force
Butylated Hydroxyanisole (BHA), CAS 25013-16-5Leave-on, rinse-off0.07%Not permitted in oral care or in products that could expose the lungs by inhalation12 months after entry into force24 months after entry into force

This is the first time CBD gets a defined concentration limit and purity threshold in Annex III rather than sitting in a regulatory grey zone, which should make formulating with it considerably more straightforward.

Annex V: Butylparaben split out, mercury preservatives phased out completely

Entry 12a currently covers Butylparaben. Under the draft, it and the new entry 12b are reshaped as follows:

EntrySubstance(s)Key limitsPlacing on the market*Making available*
12a (replaced)Propylparaben, sodium propylparaben, potassium propylparaben0.14% as acid (sum of individual concentrations); 0.8% as acid in mixtures with entries 12 and 12b, provided combined butyl- and propylparaben does not exceed 0.14%; banned in leave-on nappy-area products for children under threeNo transition statedNo transition stated
12b (new)Butylparaben, sodium butylparaben, potassium butylparabenSame general limits, plus a stricter regime for children under 10 (0.14% rinse-off, 0.002% leave-on, 0.092% oral care); banned in any sprayable product that could expose the lungs; same nappy-area warning for children under three12 months after entry into force24 months after entry into force
16 & 17 (deleted)Mercury-based preservatives (Thiomersal/Thimerosal, phenylmercuric salts)Entries removed outright; the general mercury ban in Annex II is extended to cover every mercury-containing substance without exception12 months after entry into force24 months after entry into force

*Dates for entry 12b and the deletion of entries 16 and 17 are not yet official, for the same reason noted above – the amendment is still a draft. Based on an expected adoption in late 2026, this works out to an estimated late 2027/early 2028 (placing on the market) and late 2028/early 2029 (making available).

When this takes effect

Two separate timelines apply, depending on how each change was introduced:

ChangeDeadline
The first 11 new Annex II entries and new Annex V entry 12b (tied to the CMR classifications in Delegated Regulation (EU) 2025/1222)1 February 2027
All other new bans and restrictions – placing on the market12 months after the regulation enters into force
All other new bans and restrictions – making available on the market24 months after the regulation enters into force

The placing-on-the-market and making-available split is the usual EU cosmetics pattern: the earlier date stops new stock from entering the market, the later one lets existing stock sell through.

What to do now

With the 1 February 2027 deadline already fixed for the CMR-linked changes, formulations containing any of the affected substances need to be reviewed and reformulated well ahead of that date, and CPSRs, PIFs and labelling updated to match.

CE.way can run an ingredient screen against this list for your current portfolio, flag any formulations at risk, and manage the CPSR and PIF updates once reformulation is confirmed. Get in touch at info@ceway.eu.

References

Get started

Ready to launch your cosmetic products globally?

Speak with our regulatory experts about compliance, testing, and market access requirements.

WhatsApp